Trials / Conditions / Iparomlimab and Tuvonralimab Injection
Iparomlimab and Tuvonralimab Injection
3 registered clinical trials studyying Iparomlimab and Tuvonralimab Injection — 3 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Prospective, Single-Arm, Exploratory Study of the Safety and Efficacy of Neoadjuvant Treatment With QL1706, NCT07515469 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | QL1706 in Combination With Bevacizumab and RALOX HAIC for Hepatocellular Carcinoma With Vp3/4 PVTT NCT07327788 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Recruiting | Efficacy and Safety Study of DC-CIK Cell Therapy Combined With Epaloliposide, Vortexil, and Regorafenib as Thi NCT07343791 | JIANG LONGWEI | EARLY_Phase 1 |